Cynosure Names Paul Cardarelli Vice President of Business Development
September 16 2009 - 8:30AM
PR Newswire (US)
Aesthetic Laser Industry Executive to Focus on New Business
Initiatives Including Home Use Development Program WESTFORD, Mass.,
Sept. 16 /PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ:CYNO), a
leading developer and manufacturer of a broad array of light-based
aesthetic treatment systems, today announced the appointment of
Paul B. Cardarelli as Vice President of Business Development, a new
position for the company. He will initially be responsible for the
day-to-day management of Cynosure's funded cooperative agreement
with Unilever Ltd. to develop and commercialize aesthetic devices
for the home use personal care market. "Over his nearly 20 years in
the aesthetic industry, Paul has demonstrated success in worldwide
product marketing, business development and organizational
leadership that will directly benefit Cynosure, particularly as we
expand into the home use segment of the market," said Michael
Davin, the company's president and chief executive officer. "With
Paul's technical background and strong experience in the
development of aesthetic devices, he is well suited to lead our
effort into emerging markets. While his initial focus will
primarily be managing our relationship with Unilever, we are also
excited about his ability to drive other initiatives." Before
joining Cynosure, Cardarelli worked as European Zone Director for
Ulthera Corporation, where he was responsible for the development
and implementation of a new ultrasound technology for the aesthetic
market in the European Union. Cardarelli's role at Ulthera included
engaging key opinion leaders to cultivate clinical sites, expanding
sales channels, and implementing sales and marketing training
programs. Prior to that he spent 16 years at aesthetic laser
company Candela Corporation, where he served in senior marketing
roles from 1999 to 2007. As vice president of marketing, his
accomplishments included developing strategies that significantly
expanded the company's business with non-core physicians,
implementing successful global marketing campaigns, and evaluating
potential product and technology acquisitions for product line
extensions. Previously, Cardarelli worked as associate product
manager for Candela's Urology and Cryosurgery division and later as
group product manager for the company's Dermatology and Plastic
Surgery division. About Cynosure, Inc. Cynosure, Inc. develops and
markets aesthetic treatment systems that are used by physicians and
other practitioners to perform non-invasive and minimally invasive
procedures to remove hair, treat vascular and pigmented lesions,
rejuvenate the skin, liquefy and remove unwanted fat through laser
lipolysis and temporarily reduce the appearance of cellulite.
Cynosure's products include a broad range of laser and other
light-based energy sources, including Alexandrite, pulsed dye,
Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure
was founded in 1991. For corporate or product information, contact
Cynosure at 800-886-2966, or visit http://www.cynosure.com/.
Forward-Looking Statements Any statements in this press release
about future expectations, plans and prospects for Cynosure, Inc.,
as well as other statements containing the words "believes,"
"anticipates," "plans," "expects," "will" and similar expressions,
constitute forward-looking statements within the meaning of The
Private Securities Litigation Reform Act of 1995. Actual results
may differ materially from those indicated by such forward-looking
statements as a result of various important factors, including the
global economic recession and its effects on the aesthetic laser
industry, Cynosure's history of operating losses, its reliance on
sole source suppliers, the inability to accurately predict the
timing or outcome of regulatory decisions, changes in consumer
preferences, competition in the aesthetic laser industry, economic,
market, technological and other factors discussed in Cynosure's
most recent Annual Report on Form 10-K and Quarterly Report on Form
10-Q, which are filed with the Securities and Exchange Commission.
In addition, the forward-looking statements included in this press
release represent Cynosure's views as of the date of this press
release. Cynosure anticipates that subsequent events and
developments will cause its views to change. However, while
Cynosure may elect to update these forward-looking statements at
some point in the future, it specifically disclaims any obligation
to do so. These forward-looking statements should not be relied
upon as representing Cynosure's views as of any date subsequent to
the date of this press release. Contact Scott Solomon Vice
President Sharon Merrill Associates, Inc. 617-542-5300 DATASOURCE:
Cynosure, Inc. CONTACT: Scott Solomon, Vice President of Sharon
Merrill Associates, Inc. for Cynosure, Inc., +1-617-542-5300, Web
Site: http://www.cynosure.com/
Copyright